Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyThu, 02 May 2024 06:59:25 +0200Tue, 30 Jan 2024 16:30:00 +0100Human medicines European public assessment report (EPAR): Caelyx pegylated liposomal, doxorubicin, Date of authorisation: 20/06/1996, Revision: 37, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/caelyx-pegylated-liposomalHuman medicines European public assessment report (EPAR): Caelyx pegylated liposomal, doxorubicin, Date of authorisation: 20/06/1996, Revision: 37, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/caelyx-pegylated-liposomalTue, 30 Jan 2024 16:30:00 +0100Human medicineCaelyx pegylated liposomal : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/ema-other-h-89-aa_en.pdfCaelyx pegylated liposomal : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/ema-other-h-89-aa_en.pdfFri, 27 Mar 2020 02:09:00 +0100Human medicine